Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - REVENUE
Revenue NBIX - Neurocrine Biosciences, Inc.
2.36 B
LAST VALUE
25.78%
2 YEAR CAGR
24.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR